Prognostic value of lung membrane conductance in sickle cell disease

A. Beurnier (Nantes, France), J. Graveleau (Nantes, France), T. Le Tourneau (Nantes, France), A. Masseau (Nantes, France), B. Degano (Besançon, France), B. Ricolleau (Nantes, France), F. Blanc (Nantes, France), A. Chambellan (Nantes, France)

Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Session: The value of lung function testing in various pathophysiological conditions
Session type: Thematic Poster
Number: 2433
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Beurnier (Nantes, France), J. Graveleau (Nantes, France), T. Le Tourneau (Nantes, France), A. Masseau (Nantes, France), B. Degano (Besançon, France), B. Ricolleau (Nantes, France), F. Blanc (Nantes, France), A. Chambellan (Nantes, France). Prognostic value of lung membrane conductance in sickle cell disease. 2433

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The lung in sickle cell disease
Source: Virtual Congress 2021 – Paediatric respiratory diseases
Year: 2021


Prognostic value of neutrophil to lymphocyte ratio in small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Prognostic value of apoptotic index in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Lung capillary volume in children with sickle cell disease
Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing
Year: 2007


alpha-v-beta-6 integrin may be a potential prognostic biomarker in interstitial lung disease
Source: Eur Respir J 2015; 46: 486-494
Year: 2015



Lung function and exhaled NO in children with sickle cell disease
Source: Eur Respir J 2006; 28: Suppl. 50, 708s
Year: 2006

The measurement and diagnostic value of alveolo-capillary membrane permeability determined using pulmonary clearence of Tc99m-DTPA, in diffuse interstisial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 136s
Year: 2001

Prognostic value of red cell distribution width in patients with pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Idiopathic Pulmonary Fibrosis.
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Association of wheeze with lung function decline in children with sickle cell disease
Source: Eur Respir J, 50 (5) 1602433; 10.1183/13993003.02433-2016
Year: 2017



Prognostic value of comorbidity in operated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006

Pulmonary function abnormalities in Egyptian sickle cell disease patients
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011


Evaluation of alveolar-capillary permeability of lung cancer patients
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Prognostic value of oxygenated hemoglobin (OxyHem) in fibrosing interstitial lung diseases
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020




Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003

Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Elevation of circulating endothelial cell levels in lung cancer – a new prognostic and/or predictive marker?
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008


Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small cell lung cancer (NSCLC) cells
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008